4.58
price up icon6.02%   0.26
 
loading
Precedente Chiudi:
$4.32
Aprire:
$4.34
Volume 24 ore:
331.92K
Relative Volume:
0.62
Capitalizzazione di mercato:
$166.56M
Reddito:
$425.17M
Utile/perdita netta:
$-92.21M
Rapporto P/E:
458.00
EPS:
0.01
Flusso di cassa netto:
$-67.42M
1 W Prestazione:
+8.27%
1M Prestazione:
+0.00%
6M Prestazione:
-51.22%
1 anno Prestazione:
-72.26%
Intervallo 1D:
Value
$4.34
$4.61
Intervallo di 1 settimana:
Value
$4.20
$4.82
Portata 52W:
Value
$3.95
$22.64

Nevro Corp Stock (NVRO) Company Profile

Name
Nome
Nevro Corp
Name
Telefono
650-251-0005
Name
Indirizzo
1800 BRIDGE PARKWAY, REDWOOD CITY, CA
Name
Dipendente
1,215
Name
Cinguettio
@Nevro_HF10
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
NVRO's Discussions on Twitter

Confronta NVRO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Devices icon
NVRO
Nevro Corp
4.58 166.56M 425.17M -92.21M -67.42M 0.01
Medical Devices icon
ABT
Abbott Laboratories
118.95 208.18B 41.22B 5.77B 6.49B 2.94
Medical Devices icon
SYK
Stryker Corp
388.14 148.70B 21.97B 3.59B 3.21B 6.74
Medical Devices icon
BSX
Boston Scientific Corp
90.75 133.32B 15.91B 1.79B 1.89B 0.82
Medical Devices icon
MDT
Medtronic Plc
86.27 111.27B 33.00B 4.29B 5.50B 2.71
Medical Devices icon
EW
Edwards Lifesciences Corp
72.07 42.66B 6.60B 4.16B 490.10M 2.34

Nevro Corp Stock (NVRO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-08-09 Aggiornamento Citigroup Sell → Neutral
2024-08-08 Aggiornamento Wolfe Research Underperform → Peer Perform
2024-08-07 Downgrade JMP Securities Mkt Outperform → Mkt Perform
2024-08-07 Downgrade JP Morgan Neutral → Underweight
2024-08-07 Downgrade Wells Fargo Equal Weight → Underweight
2024-05-22 Downgrade Citigroup Neutral → Sell
2024-02-22 Downgrade Oppenheimer Outperform → Perform
2024-01-12 Downgrade RBC Capital Mkts Outperform → Sector Perform
2023-12-21 Downgrade Canaccord Genuity Buy → Hold
2023-07-19 Iniziato Robert W. Baird Neutral
2023-05-31 Iniziato RBC Capital Mkts Outperform
2023-05-15 Aggiornamento Oppenheimer Perform → Outperform
2023-04-14 Iniziato Mizuho Neutral
2023-01-17 Downgrade Citigroup Buy → Neutral
2023-01-06 Downgrade Piper Sandler Neutral → Underweight
2022-12-20 Aggiornamento Canaccord Genuity Hold → Buy
2022-12-12 Downgrade Wells Fargo Overweight → Equal Weight
2022-10-12 Iniziato Jefferies Underperform
2022-05-05 Aggiornamento Citigroup Neutral → Buy
2022-04-13 Ripresa Truist Hold
2022-04-06 Iniziato Wolfe Research Underperform
2022-03-02 Ripresa BofA Securities Underperform
2022-01-07 Downgrade Morgan Stanley Overweight → Equal-Weight
2021-12-06 Aggiornamento Wells Fargo Equal Weight → Overweight
2021-11-09 Downgrade Truist Buy → Hold
2021-08-05 Downgrade Canaccord Genuity Buy → Hold
2021-08-05 Downgrade Citigroup Buy → Neutral
2021-08-05 Downgrade Piper Sandler Overweight → Neutral
2021-08-05 Downgrade Wells Fargo Overweight → Equal Weight
2021-08-05 Downgrade William Blair Outperform → Mkt Perform
2021-07-09 Downgrade Redburn Buy → Neutral
2021-07-06 Downgrade Robert W. Baird Outperform → Neutral
2021-02-02 Iniziato Piper Sandler Overweight
2020-10-23 Iniziato Guggenheim Buy
2020-09-02 Iniziato Robert W. Baird Outperform
2020-06-08 Aggiornamento UBS Sell → Neutral
2020-03-05 Iniziato Citigroup Buy
2020-02-26 Aggiornamento Canaccord Genuity Hold → Buy
2020-01-08 Iniziato SunTrust Buy
2020-01-06 Downgrade Oppenheimer Outperform → Perform
2019-11-07 Aggiornamento Oppenheimer Perform → Outperform
2019-10-22 Iniziato Oppenheimer Perform
2019-03-20 Aggiornamento BofA/Merrill Neutral → Buy
2019-03-20 Aggiornamento Wells Fargo Market Perform → Outperform
2018-11-28 Iniziato UBS Sell
2018-11-07 Downgrade BofA/Merrill Buy → Neutral
2018-11-06 Downgrade JP Morgan Overweight → Neutral
2018-11-06 Downgrade Morgan Stanley Equal-Weight → Underweight
2018-10-19 Downgrade Goldman Neutral → Sell
2018-07-02 Downgrade Morgan Stanley Overweight → Equal-Weight
2018-05-08 Reiterato Canaccord Genuity Buy
2018-05-08 Downgrade Northland Capital Outperform → Market Perform
2018-05-08 Downgrade Wells Fargo Outperform → Market Perform
Mostra tutto

Nevro Corp Borsa (NVRO) Ultime notizie

pulisher
Nov 23, 2024

Nevro Corp. (NYSE:NVRO) Receives Average Recommendation of "Reduce" from Brokerages - MarketBeat

Nov 23, 2024
pulisher
Nov 21, 2024

Nevro Stock Rises on Q3 Earnings Beat, Revenues Decrease Y/Y - MSN

Nov 21, 2024
pulisher
Nov 21, 2024

Nevro’s HFX iQ™ Spinal Cord Technology Receives CE Mark Certification in Europe - TechRound

Nov 21, 2024
pulisher
Nov 20, 2024

NVRO Stock Declines Despite Positive Study Data of Nevro1 System - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Nevro Stock May Gain on the CE Mark Certification for HFX iQ - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Nevro secures CE mark for AI-based spinal cord stimulation system - MSN

Nov 20, 2024
pulisher
Nov 19, 2024

Nevro’s SI joint fixation system delivers enhanced stability and fusion for patients - Mass Device

Nov 19, 2024
pulisher
Nov 18, 2024

Nevro announces publication of new data on Nevro1 SI Joint Fusion System - TipRanks

Nov 18, 2024
pulisher
Nov 18, 2024

New Study Demonstrates Multiple Advantages of Nevro1™ | Trending From Our Network - Chicago Star Media

Nov 18, 2024
pulisher
Nov 18, 2024

Nevro Corp announces inducement grants - Medical Buyer

Nov 18, 2024
pulisher
Nov 15, 2024

Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08 - Quantisnow

Nov 15, 2024
pulisher
Nov 15, 2024

Engaged Capital LLC Adjusts Its Stake in Nevro Corp - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires Additional Shares in Nevro Corp - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Amendment: SEC Form SC 13D/A filed by Nevro Corp. - Quantisnow

Nov 14, 2024
pulisher
Nov 14, 2024

Nevro Corp. Reports Strong Q3 2024 Financial Performance - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

Nevro Corp. (NVRO) Quarterly 10-Q Report - Quartzy

Nov 14, 2024
pulisher
Nov 14, 2024

NVRO stock touches 52-week low at $4.35 amid market challenges - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

FY2024 Earnings Forecast for Nevro Issued By William Blair - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Nevro Corp.'s SWOT analysis: stock faces headwinds amid market challenges - Investing.com Australia

Nov 14, 2024
pulisher
Nov 14, 2024

Analysts Are Updating Their Nevro Corp. (NYSE:NVRO) Estimates After Its Third-Quarter Results - Yahoo Finance

Nov 14, 2024
pulisher
Nov 13, 2024

Nevro wins CE mark for spinal cord stimulation technology - BioWorld Online

Nov 13, 2024
pulisher
Nov 13, 2024

FY2026 Earnings Estimate for Nevro Issued By William Blair - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Nevro stock price target cut, retains hold rating on earnings release - Investing.com Canada

Nov 13, 2024
pulisher
Nov 13, 2024

Nevro Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 13, 2024
pulisher
Nov 13, 2024

Nevro Corp’s Market Cap Challenges: Impairment Risks and Investor Concerns - TipRanks

Nov 13, 2024
pulisher
Nov 12, 2024

Nevro Corp stock target cut, keeps underweight rating on Q3 results - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro wins CE mark for HFX iQ spinal cord stim for pain relief - Mass Device

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro price target raised to $6 from $5 at Baird - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro stock price target cut, retains underweight on earnings beat - Investing.com

Nov 12, 2024
pulisher
Nov 12, 2024

Why Medical Device Firm Nevro Stock Is Trading Higher On TuesdayNevro (NYSE:NVRO) - Benzinga

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro (NYSE:NVRO) Price Target Cut to $7.00 by Analysts at Canaccord Genuity Group - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro's (NVRO) "Sector Perform" Rating Reiterated at Royal Bank of Canada - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Peeling Back The Layers: Exploring Nevro Through Analyst Insights - Benzinga

Nov 12, 2024
pulisher
Nov 12, 2024

Piper Sandler Cuts Nevro (NYSE:NVRO) Price Target to $6.00 - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro Corp. (NYSE:NVRO) Q3 2024 Earnings Call Transcript - MSN

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro (NYSE:NVRO) Price Target Raised to $6.00 - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro Corp stock target upgraded, neutral rating on margin outlook By Investing.com - Investing.com UK

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro Corp (NVRO) PT Lowered to $6 at Piper Sandler - StreetInsider.com

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro receives CE Mark Certification in Europe for HFX iQ SCS System - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro Corp (NVRO) PT Raised to $6 at Baird - StreetInsider.com

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally - PR Newswire

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro Corp (NVRO) PT Lowered to $7 at Canaccord Genuity - StreetInsider.com

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro price target lowered to $6 from $7 at Piper Sandler - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro Corp earnings beat by $0.40, revenue topped estimates - Investing.com Canada

Nov 12, 2024
pulisher
Nov 12, 2024

Nevro stock price target cut, retains underweight on earnings beat By Investing.com - Investing.com UK

Nov 12, 2024
pulisher
Nov 11, 2024

Nevro Corp. Shows Resilience Amidst Revenue Challenges - TipRanks

Nov 11, 2024
pulisher
Nov 11, 2024

Nevro: Q3 Earnings Snapshot - CT Insider

Nov 11, 2024
pulisher
Nov 11, 2024

Nevro Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2024 - Marketscreener.com

Nov 11, 2024

Nevro Corp Azioni (NVRO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_devices STE
$217.47
price up icon 0.65%
medical_devices ZBH
$112.02
price up icon 1.25%
medical_devices PHG
$27.15
price up icon 0.89%
$78.10
price up icon 0.21%
$83.00
price up icon 0.59%
medical_devices EW
$72.07
price up icon 0.73%
Capitalizzazione:     |  Volume (24 ore):